Partnering Opens April 15
INSIGHT • INTERACT • INVEST
Why attend Cancer Progress?
Meet with Leading Companies and Institutions at Cancer Progress 2021
Cancer Progress Conference Panels Include...
Multifunctional Soluble Biologics: Binders, Binders Everywhere
Accelerated Development Paths
Investing in the Emerald City of Oncology Innovation: Platforms & Modalities & Targets, Oh My!
Heme Malignancies Transformed: An Idiosyncratic Comparison of Multiple Myeloma and AML
Let’s Make a Deal in Oncology: What’s Behind the Doors & Who Has the Keys? Value Panel
Battle of the Modalities- The sequel
Cancer Progress 2020 Panel Summaries
As a preview of the good things to expect from Cancer Progress 2021, we’re excited to roll out summaries of select sessions from Cancer Progress 2020, starting with a summary of the panel “Paradigm Shifting Platforms II – Non-IO: Targeting Better, Targeting the Intractable” that highlights the key opportunities and challenges of non-IO targeted approaches and how even they cannot be thought of independently from IO.